Alaunos Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $0 | $124.0M | $115.1M |
| FY2021 | $16.3M | $58.1M | $76.1M |
| FY2022 | $0 | $38.6M | $39.1M |
| FY2023 | $0 | $6.3M | $6.1M |
| FY2024 | $0 | $2.1M | $1.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $0 | $124.0M | $115.1M |
| FY2021 | $16.3M | $58.1M | $76.1M |
| FY2022 | $0 | $38.6M | $39.1M |
| FY2023 | $0 | $6.3M | $6.1M |
| FY2024 | $0 | $2.1M | $1.1M |